About 15 percent of cases of an aggressive, difficult-to-detect form of ovarian cancer contain a unique fusion between two neighboring, normally separate genes, say researchers. Although gene fusions are known to occur in prostate and some blood cancers, they have been notoriously difficult to identify in solid tumors. This is the first recurrent gene fusion found for ovarian cancer.